Report of the conference(399 KB) Final Programme(95 KB) List of participants(241 KB) Speeches Session 1 – Setting the scene Session 2: Key Note Thematic Presentations Session 3: Parallel Break Out Sessions Speeches Welcome Address(34 KB)(35KB) Androulla Vassiliou, Commissioner for Health, European Commission Presentations Session 1 – Setting the scene Overview of the role of RA in decision making(301 KB) (300KB) John D. Graham Indiana University, School of Public and Environmental Affairs Proposed aims and suggested scope and Contents for the RA dialogue(83 KB)(85KB) Bernardo Delogu, Head of Unit Risk Assessment Health and Consumers Directorate General, European Commission Presentations of the Regulatory Risk Assessment process in the EU, US and Canada(526 KB)(525KB) Joint presentation by: Takis Daskaleros Health and Consumers Directorate General, European Commission Nancy Beck US Office of Management of the Budget John Giraldez Regulatory Affairs Division, Treasury Board of Canada Presentations of the Regulatory Risk Assessment process in: Japan(990 KB)(990KB) Hidetaka Kobayashi, Associate Director Food Safety and Consumer Policy Division, Food Safety and Consumer Affairs Bureau, Japan Ministry of Agriculture, Forestry and Fisheries China(332 KB)(335KB) Junshi Chen, Senior Research Professor Institute of Nutrition and Food Safety, Chinese Centre for Diseases Control and Prevention Australia(406 KB)(400KB) David Heinrich, Manager America, New Zealand, Europe and Africa Team, Plant Biosecurity, Australia Russia(139 KB)(140KB) Simon Avaliani, Head Department of the Communal Hygiene, Centre for the Risk Assessment, Russian Academy of the Advanced Medical Studies An Overview of Risk Assessment Policy Issues: Experience and Current Problems Risk Assessment Policy: an interface between risk assessment and risk management(131 KB)(140KB) Erik Millstone SPRU - Science and Technology Policy Research Freeman Centre, University of Sussex Risk Assessment and Risk Management: A Perspective From FDA(49 KB)(50KB) Randall Lutter, Deputy Commissioner for Policy US Food and Drug Administration Risk Assessment & Risk Management(133 KB)(135KB) James K. Hammit, Professor of Economics and Decision Sciences Department of Health and Policy Management, Harvard University School of Public Health, Boston, Massachusetts, USA An overview of scientific issues in risk assessment: Where are we and where should we be going?(59 KB)(60KB) Jim Bridges, Chair of the European Commission Scientific Committee on Emerging and Newly Identified Health Risks (SCENIHR) Ever increasing number of policies and risk assessments at global level – are they efficient?(2 MB)(1.3MB) Gernot Klotz, Executive Director Research and Innovation, European Chemical Industry Council (CEFIC) Session 2: Key Note Thematic Presentations Risk Assessment Terminology, Expression of Nature and Level of Risk and of Uncertainties(549 KB)(550KB) Anthony Hardy, Chair of the European Food Safety Authority (EFSA) Plant Protection Panel Considerations in light of the WHO/IPCS guidelines on expression of uncertainties(641 KB)(640KB) Gerhard Heinemeyer, Chair of WHO/IPCS Working Group on Uncertainty in Exposure Assessment Federal Institute for Risk Assessment, Germany Overview of activities to identify and assess new and emerging issues and challenges related to chemical, physical, and biological agents(300 KB)(300KB) George Gray, Assistant Administrator for the Office of Research and Development US Environmental Protection Agency State of the art in the European Union on monitoring and assessing emerging risks(356 KB)(360KB) Vittorio Silano, Chair of the Scientific Committee of the European Food Safety Authority (EFSA) Presentation of the Commission Scientific Committees draft opinion on the approach to the assessment of carcinogens and mutagens(189 KB) (190KB) Helmut Greim, Chair of the Scientific Committee on Health and Environmental Risks (SCHER) Presentation of EPA's Weight of evidence approach(345 KB) (350KB) Vicki Dellarco Health Effects Division, Office of Pesticide Programmes, US Environmental Protection Agency Presentation of the key aspects of exposure assessment in RA: needs and challenges(430 KB) (430KB) Antonia M. Calafat Division of Laboratory Sciences, National Center for Environmental Health, US Centers of Disease Control and Prevention Invited comments(800 KB)(800KB) William Ross, Director Health Canada, Bureau of Biostatistics Session 3: Parallel Break Out Sessions 1) Terminology Background discussion paper(13 KB)(20KB) Report of the break out session(46 KB)(50KB) 2) Non-Threshold Carcinogens Background discussion paper(18 KB)(20KB) Report of the break out session(37 KB)(40KB) 3) Emerging Issues and Challenges Background discussion paper(22 KB)(25KB) Report of the break out session(80 KB)(80KB) 4) Exposure Assessment Background discussion paper(45 KB)(50KB) Assessing Human Exposures for Risk Assessment and Risk Management: A U.S. Perspective(2 MB)(1MB) Valerie Zartarian and Halûk Özkaynak U.S. EPA National Exposure Research Laboratory RTP, NC Assessment of exposure to industrial substances in the EU(159 KB)(160KB) Bo Jansson Stockholm University Report of the break out session(35 KB)(40KB)